Your browser doesn't support javascript.
loading
Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs.
Cunningham, Michael J; Bock, Hailey A; Serrano, Inis C; Bechand, Benjamin; Vidyadhara, D J; Bonniwell, Emma M; Lankri, David; Duggan, Priscilla; Nazarova, Antonina L; Cao, Andrew B; Calkins, Maggie M; Khirsariya, Prashant; Hwu, Christopher; Katritch, Vsevolod; Chandra, Sreeganga S; McCorvy, John D; Sames, Dalibor.
Afiliación
  • Cunningham MJ; Department of Chemistry, Columbia University, New York, New York 10027, United States.
  • Bock HA; Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.
  • Serrano IC; Department of Chemistry, Columbia University, New York, New York 10027, United States.
  • Bechand B; Department of Chemistry, Columbia University, New York, New York 10027, United States.
  • Vidyadhara DJ; Department of Neuroscience, Department of Neurology, Yale University, New Haven, Connecticut 06510, United States.
  • Bonniwell EM; Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.
  • Lankri D; Department of Chemistry, Columbia University, New York, New York 10027, United States.
  • Duggan P; Department of Neuroscience, Barnard College, New York, New York 10027, United States.
  • Nazarova AL; Department of Quantitative and Computational Biology, Department of Chemistry, Dornsife Center for New Technologies in Drug Discovery and Development, Bridge Institute, Michelson Center for Convergent Biosciences, University of Southern California, Los Angeles, California 90089, United States.
  • Cao AB; Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.
  • Calkins MM; Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.
  • Khirsariya P; Department of Chemistry, Columbia University, New York, New York 10027, United States.
  • Hwu C; Department of Chemistry, Columbia University, New York, New York 10027, United States.
  • Katritch V; Department of Quantitative and Computational Biology, Department of Chemistry, Dornsife Center for New Technologies in Drug Discovery and Development, Bridge Institute, Michelson Center for Convergent Biosciences, University of Southern California, Los Angeles, California 90089, United States.
  • Chandra SS; Department of Neuroscience, Department of Neurology, Yale University, New Haven, Connecticut 06510, United States.
  • McCorvy JD; Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.
  • Sames D; Department of Chemistry, and Zuckerman Institute of Mind, Brain, Behavior, Columbia University, New York, New York 10027, United States.
ACS Chem Neurosci ; 14(1): 119-135, 2023 01 04.
Article en En | MEDLINE | ID: mdl-36521179
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Alucinógenos Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Humans Idioma: En Revista: ACS Chem Neurosci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Alucinógenos Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Humans Idioma: En Revista: ACS Chem Neurosci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos